Getting your player ready...
WASHINGTON — The Food and Drug Administration on Tuesday approved Amgen’s bone- strengthening drug Prolia for postmenopausal women at risk for fractures, a potential blockbuster market.
The injectable drug is given once every six months to increase bone mass and strength.
